Ovarian Cancer

A cross-sectional survey of physicians who offer women’s primary care found 33% believe transvaginal ultrasonography (TVU) and cancer antigen 125 (CA-125) to be effective screening tests for ovarian cancer, even though current clinical guidelines recommend against such screening.

Women with invasive epithelial ovarian cancer (EOC) and a germline BRCA1 or BRCA2 mutation had improved 5-year overall survival compared with those without the mutation, results of a study in the January 25 issue of JAMA has found.